Infection prevention in sarcoidosis: proposal for vaccination and prophylactic therapy

Infection prevention in sarcoidosis: proposal for vaccination and prophylactic therapy

Authors

  • Huzaefah Syed Virginia Commonwealth University
  • Christian Ascoli University of Illinois at Chicago
  • Catharina Linssen Zuyderland Medical Centre
  • Christen Vagts University of Illinois at Chicago
  • Thomas Iden Virginia Commonwealth University
  • Aamer Syed Virginia Commonwealth University
  • Jordana Kron Virginia Commonwealth University
  • Kelly Polly Virginia Commonwealth University
  • David Perkins University of Illinois at Chicago
  • Patricia Finn University of Illinois at Chicago
  • Richard Novak University of Illinois at Chicago
  • Marjolein Drent Maastricht University
  • Robert Baughman University of Cincinnati Medical Center
  • Nadera Sweiss University of Illinois at Chicago

Keywords:

Sarcoidosis, infections, opportunistic infections, vaccinations, immunizations, prophylaxis, travel

Abstract

Sarcoidosis is a systemic inflammatory disease characterized by granuloma formation in affected organs and caused by dysregulated immune response to an unknown antigen. Sarcoidosis patients receiving immunosuppressive medications are at increased risk of infection. Lymphopenia is also commonly seen among patient with sarcoidosis. In this review, risk of infections, including opportunistic infections, will be outlined. Recommendations for vaccinations and prophylactic therapy based on literature review will also be summarized.

Downloads

Published

30-06-2020

Issue

Section

Review

How to Cite

1.
Syed H, Ascoli C, Linssen C, Vagts C, Iden T, Syed A, et al. Infection prevention in sarcoidosis: proposal for vaccination and prophylactic therapy . Sarcoidosis Vasc Diffuse Lung Dis [Internet]. 2020 Jun. 30 [cited 2025 Mar. 11];37(2):87-98. Available from: https://mattioli1885journals.com/index.php/sarcoidosis/article/view/9599